Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021)

NCT07445984 is registered in ClinicalTrials.gov with Azienda Ospedaliero-Universitaria di Parma as lead sponsor.

NCT NCT07445984
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07445984 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chemogenomic Profiling in Hematological Malignancies (HEM-Profiling 2021)
Lead sponsor
Azienda Ospedaliero-Universitaria di Parma
Phase
Not applicable
Overall status
Recruiting
Start date
July 28, 2021
Completion date
July 28, 2026
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia, chronic leukemia, lymphoproliferative disorders, myelodysplastic disorders, myeloproliferative disorders